US Oncology Wins Three National Safety Council Awards

Texas Chapter Recognizes Pharmaceutical Distribution Center, Specialty
Pharmacy and Research Network

HOUSTON, March 30 /PRNewswire/ -- Three US Oncology, Inc. businesses have
received a Safety Excellence Perfect Record Award in the Occupational Safety &
Health category from the Texas chapter of the National Safety Council: US
Oncology Research, OncologyRx Care Advantage(TM), and US Oncology Specialty,
LP. This is the third time US Oncology companies have received the
Occupational Excellence Award from the national organization's Texas chapter.
More information can be found at www.usoncology.com.

The award is presented to companies, units and/or facilities that have
completed a period of at least 12 consecutive months without incurring an
occupational injury or illness that resulted in days away from work or death.

From 2007 to 2008, US Oncology Specialty, OncologyRx Care Advantage, and US
Oncology Research each achieved a zero percent incidence rate for number of
days away from work. Following are the 2008 statistics for each:

-- US Oncology Specialty, LP - 34 employees who worked 63,628 hours
-- OncologyRx Care Advantage--25 employees working 47,765 hours
-- US Oncology Research Network--16 employees who worked 29,989 hours

Formed in 1999, US Oncology collaborates with providers, payers,
biotechnology, pharmaceutical and medical equipment manufacturers to increase
patient access to advanced cancer care. US Oncology supports one of the
nation's foremost cancer treatment and research networks, accelerating the
availability and use of evidence-based medicine and shared best practices.

US Oncology Specialty, LP, is US Oncology's VAWD(TM) certified drug
distribution center focused on delivering safe and effective oncology drugs to
community-based practices. Its ePedigree technology tracks all products from
manufacturer to the practice, and back again in case of returns.

OncologyRx Care Advantage, a national oral oncology specialty pharmacy,
provides patients with convenient home delivery of oral cancer therapies and
the additional support necessary for safe and supervised use of these oral
therapy treatments. Last year the specialty pharmacy successfully expanded to
a national service offering, bringing access to home delivery of oral drugs
and critical patient support to cancer patients in all 50 U.S. states and the
territory of Puerto Rico.

The US Oncology Research network is an established community-based research
operation specializing in comprehensive Phase I-IV trials and translational
Phase I research. Supported by US Oncology, the network has played a pivotal
role in 35 cancer therapies approved by the Food and Drug Administration and
more than 38,500 patients have participated in clinical trials.

About US Oncology
US Oncology, headquartered in the Houston area, works closely with physicians,
payers, biotechnology, pharmaceutical and medical equipment manufacturers to
identify and deliver innovative services that enhance patient access to
advanced cancer care.

US Oncology uses its expertise to support every aspect of the cancer care
delivery system--from drug development to distribution and outcomes
measurement--enabling the company to help increase the efficiency and safety
of cancer care. According to the company's last quarterly earnings report, US
Oncology is affiliated with 1,211 physicians operating in 456 locations,
including 94 radiation oncology facilities in 39 states. For more information,
visit the company's Web site, www.usoncology.com.

About the National Safety Council
The National Safety Council is a nonprofit, nongovernmental, international
public service organization dedicated to protecting life and promoting health.
Members of NSC include more than 45,000 businesses, labor organizations,
schools, public agencies, private groups and individuals. Founded in 1913, and
chartered by the U.S. Congress in 1953, the primary focus of the NSC is
preventing injuries in workplaces, in transportation and in homes and
communities.

SOURCE US Oncology, Inc.

Jennifer Horspool of US Oncology, +1-281-863-6739,
Jennifer.Horspool@usoncology.com